Biphasic synthesis of biodegradable urchin-like mesoporous organosilica nanoparticles for enhanced cellular internalization and precision cascaded therapy. (17th February 2021)
- Record Type:
- Journal Article
- Title:
- Biphasic synthesis of biodegradable urchin-like mesoporous organosilica nanoparticles for enhanced cellular internalization and precision cascaded therapy. (17th February 2021)
- Main Title:
- Biphasic synthesis of biodegradable urchin-like mesoporous organosilica nanoparticles for enhanced cellular internalization and precision cascaded therapy
- Authors:
- Cheng, Yaya
Jiao, Xiangyu
Wang, Zhantong
Jacobson, Orit
Aronova, Maria A.
Ma, Yuanyuan
He, Liangcan
Liu, Yijing
Tang, Wei
Deng, Liming
Zou, Jianhua
Yang, Zhen
Zhang, Mingru
Wen, Yongqiang
Fan, Wenpei
Chen, Xiaoyuan - Abstract:
- Abstract : The excellent match-up of GOx-mimicking ultrasmall gold and biodegradable urchin-inspired mesoporous organosilica nanoparticles is expected to create a fantastic tumor microenvironment-responsive drug delivery system for precision cascaded therapy. Abstract : It is widely accepted that a small particle size and rough surface can enhance tumor tissue accumulation and tumor cellular uptake of nanoparticles, respectively. Herein, sub-50 nm urchin-inspired disulfide bond-bridged mesoporous organosilica nanoparticles (UMONs) featured with a spiky surface and glutathione (GSH)-responsive biodegradability were successfully synthesized by a facile one-pot biphasic synthesis strategy for enhanced cellular internalization and tumor accumulation. l -Arginine (LA) is encapsulated into the mesopores of UMONs, whose outer surface is capped with the gatekeeper of ultrasmall gold nanoparticles, i.e., UMONs–LA–Au. On the one hand, the mild acidity-activated uncapping of ultrasmall gold can realize a tumor microenvironment (TME)-responsive release of LA. On the other hand, the unique natural glucose oxidase (GOx)-mimicking catalytic activity of ultrasmall gold can catalyze the decomposition of intratumoral glucose to produce acidic hydrogen peroxide (H2 O2 ) and gluconic acid. Remarkably, these products can not only further facilitate the release of LA, but also catalyze the LA–H2 O2 reaction for an increased nitric oxide (NO) yield, which realizes synergistic catalysis-enhanced NOAbstract : The excellent match-up of GOx-mimicking ultrasmall gold and biodegradable urchin-inspired mesoporous organosilica nanoparticles is expected to create a fantastic tumor microenvironment-responsive drug delivery system for precision cascaded therapy. Abstract : It is widely accepted that a small particle size and rough surface can enhance tumor tissue accumulation and tumor cellular uptake of nanoparticles, respectively. Herein, sub-50 nm urchin-inspired disulfide bond-bridged mesoporous organosilica nanoparticles (UMONs) featured with a spiky surface and glutathione (GSH)-responsive biodegradability were successfully synthesized by a facile one-pot biphasic synthesis strategy for enhanced cellular internalization and tumor accumulation. l -Arginine (LA) is encapsulated into the mesopores of UMONs, whose outer surface is capped with the gatekeeper of ultrasmall gold nanoparticles, i.e., UMONs–LA–Au. On the one hand, the mild acidity-activated uncapping of ultrasmall gold can realize a tumor microenvironment (TME)-responsive release of LA. On the other hand, the unique natural glucose oxidase (GOx)-mimicking catalytic activity of ultrasmall gold can catalyze the decomposition of intratumoral glucose to produce acidic hydrogen peroxide (H2 O2 ) and gluconic acid. Remarkably, these products can not only further facilitate the release of LA, but also catalyze the LA–H2 O2 reaction for an increased nitric oxide (NO) yield, which realizes synergistic catalysis-enhanced NO gas therapy for tumor eradication. The judiciously fabricated UMONs–LA–Au present a paradigm of TME-responsive nanoplatforms for both enhanced cellular uptake and tumor-specific precision cascaded therapy, which broadens the range of practical biomedical applications and holds a significant promise for the clinical translation of silica-based nanotheranostics. … (more)
- Is Part Of:
- Biomaterials science. Volume 9:Number 7(2021)
- Journal:
- Biomaterials science
- Issue:
- Volume 9:Number 7(2021)
- Issue Display:
- Volume 9, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 9
- Issue:
- 7
- Issue Sort Value:
- 2021-0009-0007-0000
- Page Start:
- 2584
- Page End:
- 2597
- Publication Date:
- 2021-02-17
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/bm ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d1bm00015b ↗
- Languages:
- English
- ISSNs:
- 2047-4830
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.724000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 16359.xml